DXP-106 in Solid Tumor Patients.

NCT07532018 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

54

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor
Cancer

Interventions

DRUG: DXP-106

Sponsor

Singlomics Biopharmaceuticals Zhuhai Co., Ltd.